Cargando…
Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology
Giant lipid vesicles or liposomes are primarily composed of phospholipids and form a lipid bilayer structurally similar to that of the cell membrane. These vesicles, like living cells, are 5–100 μm in diameter and can be easily observed using an optical microscope. As their biophysical and biochemic...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345299/ https://www.ncbi.nlm.nih.gov/pubmed/32486297 http://dx.doi.org/10.3390/mi11060559 |
_version_ | 1783556148822016000 |
---|---|
author | Kamiya, Koki |
author_facet | Kamiya, Koki |
author_sort | Kamiya, Koki |
collection | PubMed |
description | Giant lipid vesicles or liposomes are primarily composed of phospholipids and form a lipid bilayer structurally similar to that of the cell membrane. These vesicles, like living cells, are 5–100 μm in diameter and can be easily observed using an optical microscope. As their biophysical and biochemical properties are similar to those of the cell membrane, they serve as model cell membranes for the investigation of the biophysical or biochemical properties of the lipid bilayer, as well as its dynamics and structure. Investigation of membrane protein functions and enzyme reactions has revealed the presence of soluble or membrane proteins integrated in the giant lipid vesicles. Recent developments in microfluidic technologies and synthetic biology have enabled the development of well-defined artificial cell models with complex reactions based on the giant lipid vesicles. In this review, using microfluidics, the formations of giant lipid vesicles with asymmetric lipid membranes or complex structures have been described. Subsequently, the roles of these biomaterials in the creation of artificial cell models including nanopores, ion channels, and other membrane and soluble proteins have been discussed. Finally, the complex biological functions of giant lipid vesicles reconstituted with various types of biomolecules has been communicated. These complex artificial cell models contribute to the production of minimal cells or protocells for generating valuable or rare biomolecules and communicating between living cells and artificial cell models. |
format | Online Article Text |
id | pubmed-7345299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73452992020-07-09 Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology Kamiya, Koki Micromachines (Basel) Review Giant lipid vesicles or liposomes are primarily composed of phospholipids and form a lipid bilayer structurally similar to that of the cell membrane. These vesicles, like living cells, are 5–100 μm in diameter and can be easily observed using an optical microscope. As their biophysical and biochemical properties are similar to those of the cell membrane, they serve as model cell membranes for the investigation of the biophysical or biochemical properties of the lipid bilayer, as well as its dynamics and structure. Investigation of membrane protein functions and enzyme reactions has revealed the presence of soluble or membrane proteins integrated in the giant lipid vesicles. Recent developments in microfluidic technologies and synthetic biology have enabled the development of well-defined artificial cell models with complex reactions based on the giant lipid vesicles. In this review, using microfluidics, the formations of giant lipid vesicles with asymmetric lipid membranes or complex structures have been described. Subsequently, the roles of these biomaterials in the creation of artificial cell models including nanopores, ion channels, and other membrane and soluble proteins have been discussed. Finally, the complex biological functions of giant lipid vesicles reconstituted with various types of biomolecules has been communicated. These complex artificial cell models contribute to the production of minimal cells or protocells for generating valuable or rare biomolecules and communicating between living cells and artificial cell models. MDPI 2020-05-30 /pmc/articles/PMC7345299/ /pubmed/32486297 http://dx.doi.org/10.3390/mi11060559 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kamiya, Koki Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology |
title | Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology |
title_full | Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology |
title_fullStr | Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology |
title_full_unstemmed | Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology |
title_short | Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology |
title_sort | development of artificial cell models using microfluidic technology and synthetic biology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345299/ https://www.ncbi.nlm.nih.gov/pubmed/32486297 http://dx.doi.org/10.3390/mi11060559 |
work_keys_str_mv | AT kamiyakoki developmentofartificialcellmodelsusingmicrofluidictechnologyandsyntheticbiology |